← Leaderboards
Luc Gordon Trang Morris
Sloan-Kettering Inst Can Research
$1,605,886
Attributed
$3,454,159
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $707.3K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,454,159 · 2
By mechanism
R01$2,772,409 · 1
K08$681,750 · 1
Top collaborators
- Timothy An-Thy Chan6 shared
- Alan L. Ho6 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Sarat Chandarlapaty$10,852,142
- Alan L. Ho$4,883,159
- Timothy An-Thy Chan$21,076,830
- Hikmat Al-Ahmadie$4,559,862
- Deborah Schrag$8,079,366
Others in their field
Top investigators on “Cancer Type”
- David Heimbrook · Leidos Biomedical Research, Inc.$244,136,322
- Larry Arthur$156,041,271
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Richard K. Wilson · Washington University$85,800,013
- Gregory H Reaman · National Childhood Cancer Foundation$62,692,489
- Mitchell D Schnall · University Of Pennsylvania$57,847,967
Research focus
Cancer TypeBiological MarkersMolecularEffective TherapyResearch PersonnelIn VitroGeneticMalignant NeoplasmsMutationSamplingTumorRecurrenceMouse ModelAffectNovel TherapeuticsTargeted TreatmentCheckpoint InhibitionAdenocarcinomaCheckpoint TherapyAftercareBudgetsAutologousCarcinomaClinical Investigation
Grant awards (11)
Identifying and targeting neoantigens in aggressive salivary carcinomas$455,430
R01 · FY2022 · DE · contact PI
Identifying and targeting neoantigens in aggressive salivary carcinomas$506,762
R01 · FY2021 · DE · contact PI
Identifying and targeting neoantigens in aggressive salivary carcinomas$101,802
R01 · FY2021 · DE · contact PI
Identifying and targeting neoantigens in aggressive salivary carcinomas$545,430
R01 · FY2020 · DE · contact PI
Identifying and targeting neoantigens in aggressive salivary carcinomas$592,082
R01 · FY2019 · DE · contact PI
Identifying and targeting neoantigens in aggressive salivary carcinomas$570,903
R01 · FY2018 · DE · contact PI
Functionalizing recurrent FAT1 mutations and deletions in oral cancer$136,350
K08 · FY2018 · DE · contact PI
Functionalizing recurrent FAT1 mutations and deletions in oral cancer$136,350
K08 · FY2017 · DE · contact PI
Functionalizing recurrent FAT1 mutations and deletions in oral cancer$136,350
K08 · FY2016 · DE · contact PI
Functionalizing recurrent FAT1 mutations and deletions in oral cancer$136,350
K08 · FY2015 · DE · contact PI
Functionalizing recurrent FAT1 mutations and deletions in oral cancer$136,350
K08 · FY2014 · DE · contact PI